agence france-presse
click here to return to agence france-presse main menu
DonateNow
SAfrica-AIDS: South Africa's "historic" AIDS treatment decision wins warm welcome

Agence France-Presse - August 9, 2003


CAPE TOWN, Aug 9 (AFP) - South Africa's ruling African National Congress (ANC) and its largest labour organisation gave the government a thumbs up Saturday for deciding to phase in a programme to treat its AIDS infected population.

Saadiq Kariem, the health secretary of the ANC, and the 1.7 million member Congress of South African Trade Unions (COSATU) both said the government's decision would drastically improve the lives of millions of people.

"Furthermore, it will lead to a major economic cost saving as the need to treat opportunistic infections will be decreased as well as improving the lives of the economically active part of the population," he said.

The government has been hesitant in implementing an AIDS treatment programme, despite the United Nations saying that almost 1,000 of South Africa's 4.5 million HIV/AIDS sufferers are dying every day.

On Friday however, the cabinet instructed the health ministry to develop a detailed operational plan to make antiretroviral drugs available to HIV and AIDS sufferers by the end of September.

COSATU praised "the historic announcement" and pledged to do everything in its power to work with government to implement the programme.

"We do not underestimate the scale of the challenge we face, to treat the five million people who are currently infected, but believe that this is a national emergency requiring a concerted drive by all of us to defeat this epidemic," spokesman Patrick Craven said.

The Treatment Action Campaign (TAC), which had launched a civil disobedience campaign to protest the government's policy on AIDS, applauded the decision.

"Properly implemented, this will restore hope, dignity and life for millions of people in our country. The TAC will formally suspend its civil disobedience campaign," it said.

But experts on AIDS believe it is too early for optimism.

Professor Udo Schuklenk, a specialist on AIDS ethics at South Africa's University of the Witwatersrand, said the government had been extremely hesitant in implementing a treatment programme in the past, and that they were bound to engage in more "shenanigans" in the coming months.

"The president is the king in this country and the health minister, who is a trained physician, has been compliant with breathtaking incompetence. I am sure there will be further shenanigans in the coming months," he said.

Swazi Hlubi, the executive director of the Network of AIDS Communities of South Africa, said he was hesitant about accepting the goods news.

"Our hopes have been raised and crushed many times before... we will watch closely to ensure that ARV treatment truly becomes a reality," he said.

It is widely believed that Health Minister Manto Tshabalala-Msimang has taken her cue from President Thabo Mbeki, who has stated that factors other than HIV could cause AIDS.

Tshabalala-Msimang has refused to budge on the issue of a treatment plan, despite rulings by South African courts and calls from around the world to implement such measures.

In April 2002, South Africa's highest court, the Constitutional Court, upheld a ruling by a lower court that by restricting the roll-out of the drug nevirapine, the government was violating the constitutional rights of women and their babies.

Nevirapine is used to prevent the transmission of HIV in pregnant mothers.

Last year Tshabalala-Msimang said at an AIDS conference in Barcelona that the drugs are "poisons" killing "our people".

Later she told the British newspaper, The Guardian, that budgetary priorities prevented her department from providing the drugs to HIV-positive South Africans.

In March, she recommended a combination of garlic, onions, virgin olive oil and the African potato to boost the immune systems of people with AIDS, despite a local immunology professor saying the concotion was potentially lethal.

030809
AF030845


©AFP 2003. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission. obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics. -   http://www.afp.com/

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

©1990, 2003 - AEGiS. AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.